A Phase 4 Post-marketing Study of Intramuscular Injections of BLB-750 in Healthy Adult Subjects

Clinical trial NCT03370289 · COMPLETED

Trial details

NCT number: NCT03370289
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pandemic Influenza Prevention

Start date: 2018-01-12
Primary completion: 2018-02-28
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.